1. Medtech Insight

Exec Chat: Abbott Invests In Outreach To Underrepresented Populations

 
• By Reed Miller

Jennifer Jones-McMeans, Divisional Vice President of Global Clinical Affairs at Abbott’s vascular device business, talked to Medtech Insight about her company’s ongoing efforts to diversify patient enrollment in clinical trials by communicating more effectively and compassionately with people in traditionally underrepresented demographic groups.

• Source: Shutterstock

As part of its long-term effort to improve access to its technology, Abbott is trying to reduce barriers to participation in clinical trials, especially for groups of people who have traditionally been underrepresented in clinical trials and underserved by medical technology.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D